Douglas is exiting the pharmaceutical business. The German group announced the sale of Disapo, its online portal for pharmaceutical products, to the Dutch company MYA Health, which offers services related to prescriptions and medications.

Douglas acquired Disapo in April 2022 as part of its previous strategy. However, with its new Let it Bloom – Douglas 2026 policy, introduced in early 2023, the company completely shifted its focus to concentrate on beauty.

Disapo

Disapo is headquartered in Heerlen, Netherlands, and operates from its own logistics center located near Aachen, Germany, from where it ships a wide range of over-the-counter and prescription medications, as well as cosmetics and supplements. Its team consists of approximately 90 people.

Douglas guarantees that the sale will not affect current employees or operations. MYA Health will acquire all of Disapo's activities, including inventory, logistics center, and all assets and intellectual property.

The transaction is expected to be completed by the end of July. As a result of the sale, the Douglas Group anticipates improved profitability in the future.